{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:47:28Z","timestamp":1777362448193,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s12098-026-06132-w","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:24:58Z","timestamp":1774848298000},"page":"507-514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nephrotic Syndrome: Current Management"],"prefix":"10.1007","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-0325","authenticated-orcid":false,"given":"Anil","family":"Vasudevan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8984-2479","authenticated-orcid":false,"given":"Hamsa","family":"V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"6132_CR1","doi-asserted-by":"crossref","unstructured":"Niaudet P. Nephrotic syndrome: classification and evaluation. In: Emma F, Goldstein SL, Bagga A, Bates CM, Shroff R, eds. Pediatric Nephrology. Springer; Cham; 2022, p. 255\u201360.","DOI":"10.1007\/978-3-030-52719-8_24"},{"key":"6132_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40620-021-01108-9","volume":"35","author":"J Londeree","year":"2022","unstructured":"Londeree J, McCracken CE, Greenbaum LA, et al. Estimation of childhood nephrotic syndrome incidence: data from the Atlanta metropolitan statistical area and meta-analysis of worldwide cases. J Nephrol. 2022;35:575\u201383.","journal-title":"J Nephrol"},{"key":"6132_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-3476(79)80660-5","volume":"95","author":"Nephrotic syndrome in children","year":"1979","unstructured":"Nephrotic syndrome in children. A randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the International Study of Kidney Disease in Children. J Pediatr. 1979;95:239\u201343.","journal-title":"J Pediatr"},{"key":"6132_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha A, Hari P, Sharma PK, et al. Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr. 2012;49:881\u20137.","journal-title":"Indian Pediatr"},{"key":"6132_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","volume":"58","author":"A Sinha","year":"2021","unstructured":"Sinha A, Bagga A, Banerjee S, et al; Expert Group of Indian Society of Pediatric Nephrology. Steroid sensitive nephrotic syndrome: revised guidelines. Indian Pedaitr. 2021;58:461\u201381.","journal-title":"Indian Pedaitr"},{"key":"6132_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s13312-021-2262-y","volume":"58","author":"A Vasudevan","year":"2021","unstructured":"Vasudevan A, Thergaonkar R, Mantan M, et al; Expert Group of the Indian Society of Pediatric Nephrology. Consensus guidelines on management of steroid-resistant nephrotic syndrome. Indian Pediatr. 2021;58:650\u201366.","journal-title":"Indian Pediatr"},{"key":"6132_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, et al; International Pediatric Nephrology Association. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023;38:877\u2013919.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","volume":"35","author":"A Trautmann","year":"2020","unstructured":"Trautmann A, Vivarelli M, Samuel S, et al; International Pediatric Nephrology Association. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2020;35:1529\u201361.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR9","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1016\/j.kint.2024.11.007","volume":"107","author":"J Floege","year":"2025","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Nephrotic Syndrome In Children Work Group; Floege J, Gibson KL, Vivarelli M, Liew A, Radhakrishnan J, Rovin BH. KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children. Kidney Int. 2025;107:S241\u201389.","journal-title":"Kidney Int"},{"key":"6132_CR10","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2215\/CJN.07180622","volume":"17","author":"RE Campbell","year":"2022","unstructured":"Campbell RE, Thurman JM. The immune system and idiopathic nephrotic syndrome. Clin J Am Soc Nephrol. 2022;17:1823\u201334.","journal-title":"Clin J Am Soc Nephrol"},{"key":"6132_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"304","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ. Pathogenesis of lipoid nephrosis: A disorder of T cell function. Lancet. 1974;304:556\u201360.","journal-title":"Lancet"},{"key":"6132_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00467-009-1194-x","volume":"24","author":"XS Shao","year":"2009","unstructured":"Shao XS, Yang XQ, Zhao XD, et al. The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome. Pediatr Nephrol. 2009;24:1683\u201390.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12675","author":"R Bertelli","year":"2015","unstructured":"Bertelli R, Bonanni A, Di Donato A, Cioni M, Ravani P, Ghiggeri GM. Regulatory T cells and minimal change nephropathy: in the midst of a complex network. Clin Exp Immunol. 2015. https:\/\/doi.org\/10.1111\/cei.12675.","journal-title":"Clin Exp Immunol"},{"key":"6132_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00467-010-1676-x","volume":"26","author":"M Shimada","year":"2011","unstructured":"Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH. Minimal change disease: a \u2018two-hit\u2019 podocyte immune disorder? Pediatr Nephrol. 2011;26:645\u20139.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR15","first-page":"531","volume":"10","author":"S Zhu","year":"2024","unstructured":"Zhu S, Zhang J, Gao L, Ye Q, Mao J. The pathogenesis of nephrotic syndrome: a perspective from B cells. Kidney Dis. 2024;10:531\u201344.","journal-title":"Kidney Dis"},{"key":"6132_CR16","doi-asserted-by":"publisher","DOI":"10.1159\/000550052","author":"J Wang","year":"2026","unstructured":"Wang J, Chen J, Chen Z, Guo Z, Bao H. Association between anti-nephrin antibodies and podocytopathies: a systematic review and meta-analysis. Nephron. 2026. https:\/\/doi.org\/10.1159\/000550052.","journal-title":"Nephron"},{"key":"6132_CR17","doi-asserted-by":"publisher","first-page":"sfaf100","DOI":"10.1093\/ckj\/sfaf100","volume":"18","author":"FE Hengel","year":"2025","unstructured":"Hengel FE, Huber TB, Tomas NM. Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases. Clin Kidney J. 2025;18:sfaf100.","journal-title":"Clin Kidney J"},{"key":"6132_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"6132_CR19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1681\/ASN.2014050489","volume":"26","author":"CE Sadowski","year":"2015","unstructured":"Sadowski CE, Lovric S, Ashraf S, et al; SRNS Study Group, Hildebrandt F. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015;26:1279\u201389.","journal-title":"J Am Soc Nephrol"},{"key":"6132_CR20","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/s41467-023-37985-w","volume":"14","author":"A Barry","year":"2023","unstructured":"Barry A, McNulty MT, Jia X, et al. Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome. Nat Commun. 2023;14:2481.","journal-title":"Nat Commun"},{"key":"6132_CR21","first-page":"CD001533","volume":"8","author":"D Hahn","year":"2024","unstructured":"Hahn D, Samuel SM, Willis NS, Craig JC, Hodson EM. Corticosteroid therapy for nephrotic syndrome in children. Cochrane database Syst Rev. 2024;8:CD001533.","journal-title":"Cochrane database Syst Rev"},{"key":"6132_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","volume":"87","author":"A Sinha","year":"2015","unstructured":"Sinha A, Saha A, Kumar M, et al. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int. 2015;87:217\u201324.","journal-title":"Kidney Int"},{"key":"6132_CR23","doi-asserted-by":"publisher","first-page":"I1800","DOI":"10.1136\/bmj.l1800","volume":"365","author":"NJA Webb","year":"2019","unstructured":"Webb NJA, Woolley RL, Lambe T, et al; PREDNOS Collaborative Group. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation. BMJ. 2019;365:I1800.","journal-title":"BMJ"},{"key":"6132_CR24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s10157-020-01875-y","volume":"24","author":"B Basu","year":"2020","unstructured":"Basu B, Bhattacharyya S, Barua S, Naskar A, Roy B. Efficacy of body weight vs. body surface area-based prednisolone regimen in nephrotic syndrome. Clin Exp Nephrol. 2020;24:622\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"6132_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00467-015-3285-1","volume":"31","author":"V Raman","year":"2016","unstructured":"Raman V, Krishnamurthy S, Harichandrakumar KT. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial. Pediatr Nephrol. 2016;31:595\u2013604.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997;8:769\u201376.","journal-title":"J Am Soc Nephrol"},{"key":"6132_CR27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2215\/CJN.0000000000000288","volume":"18","author":"C Dossier","year":"2023","unstructured":"Dossier C, Bonneric S, Baudouin V, et al. Obinutuzumab in frequently relapsing and steroid-dependent nephrotic syndrome in children. Clin J Am Soc Nephrol. 2023;18:1555\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"6132_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.32598\/jpr.8.4.857.1","volume":"8","author":"Y Ravanshad","year":"2020","unstructured":"Ravanshad Y, Golsorkhi M, Ravanshad S, et al. A systematic review of efficacy and safety of ofatumumab therapy in children with difficult-to-treat nephrotic syndrome. J Pediatr Rev. 2020;8:223\u20138.","journal-title":"J Pediatr Rev"},{"key":"6132_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fped.2018.00200","volume":"6","author":"A Trautmann","year":"2018","unstructured":"Trautmann A, Lipska-Zi\u0229tkiewicz BS, Schaefer F. Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: The Podonet Registry. Front Pediatr. 2018;6:200.","journal-title":"Front Pediatr"},{"key":"6132_CR30","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00467-020-04476-9","volume":"36","author":"JM Lee","year":"2021","unstructured":"Lee JM, Kronbichler A, Shin J, Il, Oh J. Current understandings in treating children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2021;36:747\u201361.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR31","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00467-024-06634-9","volume":"40","author":"EY Chan","year":"2025","unstructured":"Chan EY, Boyer O. Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines. Pediatr Nephrol. 2025;40:2431\u201342.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jpeds.2018.01.008","volume":"197","author":"M Jellouli","year":"2018","unstructured":"Jellouli M, Charfi R, Maalej B, Mahfoud A, Trabelsi S, Gargah T. Rituximab in the management of pediatric steroid-resistant nephrotic syndrome: a systematic review. J Pediatr. 2018;197:191\u20137.e1.","journal-title":"J Pediatr"},{"key":"6132_CR33","doi-asserted-by":"publisher","first-page":"e13469","DOI":"10.1111\/petr.13469","volume":"23","author":"LJ Koh","year":"2019","unstructured":"Koh LJ, Martz K, Blydt-Hansen TD; NAPRTCS Registry Investigators. Risk factors associated with allograft failure in pediatric kidney transplant recipients with focal segmental glomerulosclerosis. Pediatr Transpl. 2019;23:e13469.","journal-title":"Pediatr Transpl"},{"key":"6132_CR34","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1111\/ctr.15119","volume":"37","author":"J Bai","year":"2023","unstructured":"Bai J, Yin X, Li J, et al. Incidence, risk factors, and outcomes of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: a systematic review and meta-analysis. Clin Transpl. 2023;37:e1159.","journal-title":"Clin Transpl"},{"key":"6132_CR35","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00467-013-2525-5","volume":"29","author":"BA Kerlin","year":"2014","unstructured":"Kerlin BA, Haworth K, Smoyer WE. Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol. 2014;29:989\u201397.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR36","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.2215\/CJN.06620615","volume":"10","author":"MN Rheault","year":"2015","unstructured":"Rheault MN, Zhang L, Selewski DT, et al; Midwest Pediatric Nephrology Consortium. AKI in children hospitalized with nephrotic syndrome. Clin J Am Soc Nephrol. 2015;10:2110\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"6132_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fped.2016.00053","volume":"4","author":"R Hjorten","year":"2016","unstructured":"Hjorten R, Anwar Z, Reidy KJ. Long-term outcomes of childhood onset nephrotic syndrome. Front Pediatr. 2016;4:53.","journal-title":"Front Pediatr"},{"key":"6132_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet. 2018;392:61\u201374.","journal-title":"Lancet"},{"key":"6132_CR39","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(23)01051-6","volume":"402","author":"M Vivarelli","year":"2023","unstructured":"Vivarelli M, Gibson K, Sinha A, Boyer O. Childhood nephrotic syndrome. Lancet. 2023;402:809\u201324.","journal-title":"Lancet"},{"key":"6132_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5414\/CN108044","volume":"81","author":"P Skrzypczyk","year":"2014","unstructured":"Skrzypczyk P, Pa\u0144czyk-Tomaszewska M, Roszkowska-Blaim M, et al. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood. Clin Nephrol. 2014;81:166\u201373.","journal-title":"Clin Nephrol"},{"key":"6132_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.25259\/IJN_5_2024","volume":"35","author":"J Shukla","year":"2025","unstructured":"Shukla J, Gupta A, Kalra R. Quality of life of children with idiopathic nephrotic syndrome. Indian J Nephrol. 2025;35:234\u201342.","journal-title":"Indian J Nephrol"},{"key":"6132_CR42","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00467-015-3136-0","volume":"30","author":"AC Mendon\u00e7a","year":"2015","unstructured":"Mendon\u00e7a AC, Oliveira EA, Fr\u00f3es BP, et al. A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome. Pediatr Nephrol. 2015;30:2011\u201320.","journal-title":"Pediatr Nephrol"},{"key":"6132_CR43","doi-asserted-by":"crossref","unstructured":"Kemper MJ, Gibson K, Sinha A. Nongenetic forms of steroid-resistant nephrotic syndrome. In: Emma F, Goldstein SL, Bagga A, Bates CM, Shroff R, eds. Pediatric Nephrology. Springer: Cham; 2022. p. 387\u2013410.","DOI":"10.1007\/978-3-030-52719-8_93"},{"key":"6132_CR44","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3389\/fimmu.2019.01669","volume":"10","author":"K Kienzl-Wagner","year":"2019","unstructured":"Kienzl-Wagner K, Waldegger S, Schneeberger S. Disease recurrence- The sword of damocles in kidney transplantation for primary focal segmental glomerulosclerosis. Front Immunol. 2019;10:1669.","journal-title":"Front Immunol"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-026-06132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-026-06132-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-026-06132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:59:02Z","timestamp":1777359542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-026-06132-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["6132"],"URL":"https:\/\/doi.org\/10.1007\/s12098-026-06132-w","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}